Analysts have identified top-performing stocks with the potential to gain up to 46%, based on their strong financials and promising growth outlook. This article provides key insights to help investors discover valuable opportunities in a fast-changing market.
Below List are a few stocks suggested by analysts with a high growth potential of up to 46 percent:
Ethos Ltd
With a market capitalization of Rs. 6,823.21 crore, the shares of Ethos Ltd closed at Rs. 2,550 per equity share, down nearly 0.65 percent from its previous day’s close price of Rs. 2,566.80.
Brokerage firm Yes Securities has given a “Buy” rating on Ethos Ltd, with a target price of Rs. 3,722 per share, implying a potential upside of 45.96%. Ethos Watches, promoted by KDDL Limited and founded in 2007, is India’s largest luxury watch retail chain, with over 70 stores and over 70 premium watch brands. It enables customers to select genuine watches while protecting them from smuggled, fake, and refurbished products.
NTPC
With a market capitalization of Rs. 3,26,729.17 crore, the shares of NTPC closed at Rs. 336.95 per equity share, down nearly 0.55 percent from its previous day’s close price of Rs. 338.80.
ICICI Securities Ltd has issued a “Buy” recommendation on NTPC Limited, setting a target price of Rs. 439 per share, with an upside potential of 30.28%. National Thermal Power Corporation (NTPC) Ltd, along with its subsidiaries and joint ventures, is engaged in the production and distribution of bulk electricity to state power utilities. In addition, the group operates in coal mining, oil and gas exploration, energy trading, project management, and consulting services.
Suzlon Energy Ltd
With a market capitalization of Rs. 80,428.45 crore, the shares of Suzlon Energy Ltd closed at Rs. 58.68 per equity share, up by 0.89 percent from its previous day’s close price of Rs. 58.16.
Geojit BNP Paribas, a reputed brokerage firm, has recommended a “Buy” rating on Suzlon Energy Ltd, projecting a potential upside of 29% with a target price of Rs. 75 per share.
Suzlon is a leading global renewable energy company that manufactures vertically integrated wind turbine generators. It offers design, manufacture, installation, operation, and maintenance of turbines and components such as rotor blades, towers, generators, and nacelles.
Ador Welding Ltd
With a market capitalization of Rs. 1,583.66 crore, the shares of Ador Welding Ltd closed at Rs. 910 per equity share, up nearly by 0.31 percent from its previous day’s close price of Rs. 907.20.
IDBI Capital has recommended buying shares of Ador Welding Ltd, assigning a target price of Rs. 1,151, which reflects an expected upside of 26.48%. Ador Welding Ltd is a leading supplier of welding products, technologies, and services, providing tailored solutions to refineries, oil and gas, petrochemicals, and other industries. The company has over 850 employees, 5 manufacturing facilities, serves 31,235 pin codes in India, and operates in 15+ countries worldwide, producing 90,000 MT of welding consumables and 30,000 welding power sources each year.
JSW Infrastructure Ltd
With a market capitalization of Rs. 64,113.05 crore, the shares of JSW Infrastructure Ltd closed at Rs. 305.30 per equity share, down nearly 1.12 percent from its previous day’s close price of Rs. 308.75.
Motilal Oswal Financial Services, a prominent brokerage and financial services firm, has recommended a “Buy” call on JSW Infrastructure Ltd with a target price of Rs. 380 per share, indicating an upside potential of 24.47 percent.
JSW Infrastructure, a member of the JSW Group, is India’s second-largest private port operator, with a cargo handling capacity of 170 MTPA across ten ports and terminals. It provides efficient and environmentally friendly port services for a variety of cargo types, such as dry bulk, liquid bulk, gases, and containers. Internationally, it operates a 465,000 cubic meter liquid storage facility and two dry bulk terminals in Fujairah and Dibba, UAE, establishing a significant global presence.
Glenmark Pharmaceuticals Ltd
With a market capitalization of Rs. 54,746.96 crore, the shares of Glenmark Pharmaceuticals Ltd closed at Rs. 1,940 per equity share, down by 0.05 percent from its previous day’s close price of Rs. 1,940.90.
Leading brokerage firm Motilal Oswal Financial Services has suggested a “Buy” call on Glenmark Pharmaceuticals Ltd, projecting to a 23.88 percent upside potential with a target price of Rs. 2400 per share.
Glenmark Pharmaceuticals is a global research-driven company that manufactures branded, generic, and over-the-counter drugs, with a focus on respiratory, dermatology, and oncology. Innovative drugs and specialty products are developed by the company, which has R&D centers and manufacturing operations in over 80 countries across five continents. It also works on cancer treatments through its US subsidiary, with the goal of providing effective solutions to patients all over the world.
Written By Akshay Sanghavi
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Stocks to Buy: 6 Stocks that can deliver returns of up to 46%; Do you own any? appeared first on Trade Brains.